Effect of Beta-Blockers on Mortality after Myocardial Infarction in Adults with COPD
Published Online: Thursday, January 16, 2014
Jennifer Quint, clinical lecturer in epidemiology at the London School of Hygiene and Tropical Medicine, and Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, discuss their BMJ study of UK COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.
A new test cleared by the FDA will help determine a patient’s risk of coronary heart disease events, such as a heart attack.
Most patients don’t receive counseling about resuming sexual activity after having a heart attack.